| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| Cell and Tissue Preservation Market Size 2023 |
USD 5085 million |
| Cell and Tissue Preservation Market, CAGR |
10.55% |
| Cell and Tissue Preservation Market Size 2032 |
USD 11343.8 million |
Market Overview:
The Cell and Tissue Preservation Market is projected to grow from USD 5085 million in 2024 to an estimated USD 11343.8 million by 2032, with a compound annual growth rate (CAGR) of 10.55% from 2024 to 2032.
Key drivers fueling the growth of the cell and tissue preservation market include the rising incidence of chronic diseases such as cancer, cardiovascular disorders, and diabetes, which often necessitate regenerative treatments and organ transplants. The expanding role of biobanking, particularly in research and personalized medicine, is further propelling market growth. Cryopreservation technologies have seen significant advancements, improving the viability and longevity of preserved cells and tissues, which is critical for their applications in organ transplants, drug discovery, and stem cell research. Government initiatives and substantial funding for the development of cell and tissue storage infrastructure are enhancing market adoption, while increasing awareness about the benefits of organ and tissue donation has contributed to higher demand. Additionally, the market is witnessing a surge in innovation, with companies developing novel preservation methods that offer longer storage times, reduced tissue degradation, and improved post-thaw recovery rates, ensuring the integrity of the preserved materials.
Regionally, North America continues to dominate the global cell and tissue preservation market, largely due to its advanced healthcare infrastructure, strong regulatory support, and increasing investments in biomedical research and biobanking. The presence of key market players, coupled with a high demand for organ transplants and stem cell research, further bolsters the region’s leadership. Europe follows closely, driven by stringent regulatory frameworks, a well-established biobanking network, and growing government support for regenerative medicine initiatives. Asia Pacific, however, is expected to witness the fastest growth during the forecast period, with rising healthcare investments, expanding biobanking facilities, and a growing focus on organ donation and transplantation. Countries like China, India, and Japan are spearheading growth in this region. Meanwhile, Latin America and the Middle East & Africa are emerging markets, showing promising potential as healthcare infrastructure improves and awareness regarding tissue preservation grows across these regions.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Drivers:
Increasing Prevalence of Chronic Diseases:
One of the primary drivers of the cell and tissue preservation market is the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. These diseases often require regenerative treatments, including cell therapy, organ transplants, and stem cell-based therapies. As the global burden of chronic diseases increases, the demand for advanced preservation solutions to store cells and tissues for medical use has also surged. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 133 million Americans have at least one chronic disease. In addition, regenerative medicine and personalized treatment approaches rely heavily on the availability of high-quality preserved cells, tissues, and organs, further pushing the growth of the market.
Advancements in Cryopreservation Technologies:
Technological advancements in cryopreservation have significantly improved the efficiency and reliability of cell and tissue storage, enhancing the overall market growth. Innovations such as vitrification, which prevents the formation of ice crystals during the freezing process, have resulted in better post-thaw cell viability and tissue integrity. These advancements are particularly beneficial in areas like stem cell research, organ transplantation, and reproductive medicine, where the quality of preserved materials directly impacts treatment success. As new cryoprotective agents and freezing techniques are developed, the market is expected to witness further growth, driven by the demand for advanced preservation methods in various biomedical applications.
Expanding Applications of Biobanking:
The expanding role of biobanking in clinical research, drug discovery, and personalized medicine is another critical factor driving the cell and tissue preservation market. Biobanks play an essential role in the storage and management of biological specimens, such as cells, tissues, and organs, for future use in research and therapeutic applications. With the growing need for long-term preservation of biological samples for genomic studies, cancer research, and regenerative therapies, biobanking has become an integral part of healthcare systems. As a result, the increasing number of biobanks and the rising demand for preserved biological materials are contributing significantly to the growth of the market.
Government Support and Regulatory Frameworks:
Governments around the world are actively supporting the development of cell and tissue preservation infrastructure through funding, policy initiatives, and regulatory frameworks. These efforts aim to promote organ donation, stem cell research, and the development of new preservation techniques. In regions like North America and Europe, well-established regulatory systems ensure the safe and ethical storage of biological materials, encouraging greater adoption of preservation technologies. For example, the European Union has implemented stringent regulations to ensure the quality and safety of preserved tissues and cells. Furthermore, government-funded biobanking programs and public awareness campaigns on the importance of tissue donation are helping to drive market expansion. According to a survey by the World Health Organization (WHO), government funding for biobanking programs has increased by 25% in the past three years. As more countries recognize the value of preserved cells and tissues for medical advancements, the market for cell and tissue preservation is expected to experience substantial growth in the coming years.
Market Trends:
Growing Focus on Regenerative Medicine and Stem Cell Research:
A significant trend in the cell and tissue preservation market is the increasing focus on regenerative medicine and stem cell research. As advancements in regenerative therapies continue to accelerate, the demand for reliable cell and tissue preservation methods has surged. Stem cells, with their potential to regenerate damaged tissues and treat a wide range of diseases, require long-term storage solutions to maintain their viability. For instance, AstraZeneca is exploring stem cell therapies to treat chronic kidney and liver diseases. According to a study published in the Journal of Regenerative Medicine, stem cell therapies have shown a success rate of over 70% in regenerating damaged tissues. This trend is driving innovation in cryopreservation technologies and boosting the adoption of advanced storage solutions, which are essential for maintaining the integrity of these cells over extended periods. Research institutions and biotechnology companies are investing heavily in improving preservation techniques, fueling growth in the market.
Technological Advancements in Cryopreservation Methods:
Technological innovation remains at the forefront of market trends, with advancements in cryopreservation methods contributing significantly to the growth of the cell and tissue preservation market. Techniques like vitrification, which prevent the formation of ice crystals, are revolutionizing the way cells and tissues are preserved, ensuring higher post-thaw viability and integrity. Automated cryogenic storage systems are also gaining traction, providing more efficient, reliable, and scalable storage options for medical and research institutions. These technological advancements are expected to enhance the preservation of complex tissues, including organs and reproductive cells, driving wider adoption in both clinical and research settings.
Expansion of Biobanking and Personalized Medicine:
Biobanking is becoming an integral part of healthcare and research, with its expansion serving as a critical trend in the cell and tissue preservation market. Biobanks store biological samples such as cells, tissues, and organs for future use in research, drug discovery, and personalized medicine. As personalized medicine continues to grow, there is an increasing need for large repositories of preserved biological materials. This trend is encouraging both public and private sectors to invest in biobanking infrastructure, thereby contributing to the expansion of the cell and tissue preservation market. The ability to store and utilize preserved cells and tissues for individualized treatment plans is a driving force in the future of healthcare.
Rising Government Initiatives and Regulatory Support:
The cell and tissue preservation market is also witnessing a trend of increased government initiatives and regulatory support aimed at advancing biobanking and preservation technologies. Governments across regions such as North America, Europe, and Asia Pacific are providing funding and setting up policies to support the development of biobanks and stem cell research centers. These initiatives include grants for research, subsidies for building preservation infrastructure, and the establishment of ethical guidelines for tissue storage and use. For instance, the International Agency for Research on Cancer (IARC) has noted that biobanks are foundational for molecular and genetic epidemiology, molecular pathology, and pharmacogenomics. According to a report by the EPMA Journal, biobanks have supported over 10,000 research projects globally. This regulatory framework ensures safe, standardized, and ethical practices, fostering growth in the market by encouraging wider adoption of preservation technologies in medical and research institutions.
Market Restraints and Challenges:
High Costs of Cryopreservation Technologies:
One of the key restraints in the cell and tissue preservation market is the high cost associated with advanced cryopreservation technologies. The development and maintenance of cryogenic storage facilities, along with the specialized equipment required for preserving cells and tissues, involve significant capital investment. For smaller healthcare facilities, research institutions, and biobanks, these costs can be prohibitive, limiting their ability to adopt state-of-the-art preservation methods. Additionally, the ongoing operational costs, such as liquid nitrogen storage, monitoring systems, and specialized staff, further add to the financial burden, which may slow market growth in cost-sensitive regions.
Technical Challenges in Preserving Complex Tissues and Organs:
Preserving complex tissues and organs for long periods poses significant technical challenges. While cryopreservation techniques have advanced for cells and simpler tissues, the preservation of whole organs remains a critical challenge due to issues such as ice crystal formation, which can cause damage during freezing and thawing. Maintaining the viability and structural integrity of large, complex tissues during long-term storage requires further innovation. The lack of reliable methods for organ preservation continues to hinder advancements in areas such as organ transplantation, where demand far exceeds supply.
Limited Awareness and Infrastructure in Developing Regions:
Another challenge the market faces is the limited awareness and underdeveloped infrastructure for cell and tissue preservation in developing regions. Many countries in Asia, Africa, and Latin America lack the necessary healthcare infrastructure and resources to implement advanced preservation techniques. Moreover, public awareness regarding the importance of biobanking and tissue preservation for future medical applications is low in these regions. This creates a gap in the global adoption of cell and tissue preservation technologies, limiting market expansion in emerging economies.
Market Segmentation Analysis:
By type, the market is divided into cell and tissue preservation. The cell segment includes mammalian cells and others, such as microorganisms and plant cells. The tissue segment covers blood, bone, soft tissues, skin, and other tissues. Tissue preservation, particularly in blood and bone, plays a significant role in medical treatments, including transplants and regenerative therapies.
By application, the market is categorized into therapeutics, drug discovery, gene therapy, IVF treatment, cell therapy, and research & development. Therapeutics and cell therapy are expected to see substantial growth due to the increasing demand for regenerative medicine and organ transplantation. Research & development also remains a key area, driving demand for preserved cells and tissues in various studies.
By product, the market comprises equipment (freezers, refrigerators, storage systems), software, and bio-preservation media, with bio-preservation media further divided into home-brew and pre-formulated media. Equipment forms the backbone of preservation processes, with freezers and storage systems being critical in maintaining optimal preservation conditions.
By end user, the market is segmented into biobanks and hospitals. Biobanks are essential in storing biological materials for research and therapeutic purposes, while hospitals are key users for clinical applications, particularly in treatments and transplants. The growing demand for biobanking and advanced storage solutions in hospitals is driving this segment’s expansion.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Segmentation:
By Type
- Cell
- Mammalian Cells
- Others (Microorganisms and Plant Cells)
- Tissue
- Blood
- Bone
- Soft Tissues
- Skin
- Others
By Application
- Therapeutics
- Drug Discovery
- Gene therapy
- IVF treatment
- Cell therapy
- Research & Development
By Product
- Equipment
- Freezers
- Refrigerators
- Storage Systems
- Others
- Software
- Bio-preservation Media
- Home-brew Media
- Pre-formulated Media
By End User
By Region
- North America
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Regional Analysis:
North America
North America dominates the global cell and tissue preservation market, accounting for approximately 40% of the total market share. The region’s leadership is driven by its advanced healthcare infrastructure, extensive research activities, and significant government funding for biobanking and regenerative medicine. The United States, in particular, is a major contributor, with numerous biobanks, research institutions, and stem cell therapy centers driving market growth. The strong presence of key market players and the growing demand for organ transplants, as well as advancements in cryopreservation technologies, further support the market’s expansion in this region. Regulatory frameworks in North America are well-established, ensuring safe and ethical practices in cell and tissue storage, contributing to the market’s continued growth.
Europe
Europe holds the second-largest market share, capturing around 30% of the global cell and tissue preservation market. The region’s growth is driven by stringent regulatory frameworks, a well-established healthcare system, and a focus on research in areas like stem cell therapy and regenerative medicine. Countries such as Germany, the UK, and France lead in biobanking and preservation technologies due to strong government support and funding. The increasing demand for organ transplantation and advancements in personalized medicine are further driving the need for efficient cell and tissue preservation in the region. Europe’s focus on ethical storage and utilization of biological materials positions it as a critical player in the global market.
Asia Pacific
Asia Pacific is expected to experience the fastest growth in the cell and tissue preservation market, with a projected CAGR higher than that of other regions. Currently, it holds around 20% of the market share, but this is expected to increase significantly during the forecast period. Countries such as China, Japan, and India are at the forefront of growth, with expanding healthcare investments, increasing awareness about biobanking, and rising demand for organ transplants. The region is also seeing substantial developments in stem cell research, which is boosting the demand for advanced preservation methods. As healthcare infrastructure improves and public awareness increases, Asia Pacific is set to emerge as a key region for market expansion.
Latin America and Middle East & Africa
Latin America and the Middle East & Africa currently account for the remaining 10% of the global cell and tissue preservation market. These regions are still in the nascent stages of adopting advanced preservation technologies. However, improving healthcare infrastructure, growing awareness about organ donation, and increasing government initiatives are expected to support moderate growth in these regions. Brazil, South Africa, and the UAE are emerging markets within these regions, showing promising potential for future market expansion as investments in biobanking and healthcare technologies increase.
Key Player Analysis:
- Agilent Technologies, Inc.
- AMSBIO
- Avantor, Inc.
- BD
- BioLifeSolutions Inc.
- CellGenix GmbH
- Corning Incorporated
- Cytiva
- FUJIFILM Irvine Scientific
- LGC SeraCare
- Lonza
- MerckKGaA
- Princeton CryoTech
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific, Inc.
Competitive Analysis:
The cell and tissue preservation market is highly competitive, with several key players driving innovation and growth. Leading companies such as Thermo Fisher Scientific, BioLife Solutions, Inc., Merck KGaA, and GE Healthcare dominate the market due to their extensive product portfolios, advanced cryopreservation technologies, and strong global presence. These players are actively investing in research and development to enhance preservation methods and improve the viability of preserved cells and tissues. Smaller companies and emerging players, such as Cryoport, Inc. and BioCision, are also gaining traction by offering specialized products and services tailored to niche markets like stem cell research and organ preservation. Strategic collaborations, mergers, and acquisitions are common, as companies seek to expand their market reach and enhance their technological capabilities. The competitive landscape is marked by continuous innovation, with players focusing on developing cost-effective, reliable, and scalable preservation solutions to meet the growing demand for regenerative medicine and biobanking.
Recent Developments:
- On February 29, 2024, STEMCELL Technologies acquired substantially all assets of SQZ Biotechnologies Company. This acquisition included SQZ’s portfolio of over 400 patents and trademarks, proprietary equipment, and other intellectual property. The acquisition gives STEMCELL access to SQZ’s innovative cell therapy delivery technology.
- In January 2024, STEMCELL Technologies purchased Propagenix Inc., a Maryland-based biotechnology company focused on developing technologies for regenerative medicine.
- OrganaBio launched a new product called HematoPAC-HSC-CB-GMP on April 3, 2024. This product is an on-demand current good manufacturing practice (cGMP)-compliant CD34+ hematopoietic stem cell source for advanced therapy manufacturing. While not explicitly stated as a partnership, this launch likely involves collaboration with other entities in the cell therapy industry.
Market Concentration & Characteristics:
The cell and tissue preservation market exhibits moderate market concentration, with a few large players holding significant market share, while several smaller and specialized companies compete in niche segments. Leading companies like Thermo Fisher Scientific, Merck KGaA, and GE Healthcare dominate the market due to their extensive product portfolios, global distribution networks, and strong research and development capabilities. The market is characterized by continuous innovation, driven by the growing demand for advanced cryopreservation techniques and long-term storage solutions for cells, tissues, and organs. Companies are focusing on developing more efficient and cost-effective preservation methods, as well as expanding their offerings to cater to the growing fields of regenerative medicine, stem cell research, and organ transplantation. Additionally, strategic partnerships and acquisitions are common as players seek to enhance their technological expertise and broaden their market reach in this highly competitive and evolving industry.
Report Coverage:
The research report offers an in-depth analysis based on By Type, By Application, By Product and By End User. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- Advancements in cryopreservation techniques will enhance the viability of preserved cells and tissues, driving wider adoption across medical applications.
- Increasing demand for regenerative medicine and stem cell therapies will continue to boost the need for reliable preservation methods.
- Expansion of biobanking infrastructure globally will support long-term storage of biological materials for research and therapeutic use.
- Rising organ transplantation rates will necessitate improved preservation solutions for organs and complex tissues.
- Technological innovations, such as automated storage systems, will streamline preservation processes and improve efficiency.
- Emerging markets in Asia Pacific and Latin America will see rapid growth due to improving healthcare infrastructure and growing awareness.
- Public and private investments in cell therapy research will create opportunities for new entrants and drive market expansion.
- Government initiatives and favorable regulatory frameworks will support the development of biobanking and tissue preservation infrastructure.
- Strategic collaborations and mergers will reshape the competitive landscape, as companies seek to strengthen their technological capabilities.
- Increased focus on personalized medicine will drive demand for biobanked cells and tissues, further expanding the market.
